 |
 |
||||||||||||||||
|
Research
Publications
2000-2003
Borer JS. First-pass and equilibrium radionuclide angiography in Atlas of Nuclear Cardiology (eds: Dilsizian V, Narula J, Braunwald E), Current Medicine, Inc: Philadelphia, 2003, pp 147-166. White WB, Faich G, Borer JS, Makuch RW. Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib. American Journal of Cardiology 2003;92:411-418. Borer JS, Fox K, Jaillon P, Lerebours G, for the European Ivabradine Investigators. Anti-anginal and anti-ischemic effects of ivabradine, an If inhibitor, in stable angina: a randomized, double-blinded, multicentered, placebo-controlled trial. Circulation 2003;107:817-823. Supino, PG, Schuleri K, Gupta A, Borer JS. Management of valvular heart disease in the elderly. Cardiology Review 2003;20:24-31. Borer JS, Bonow RO. Contemporary approach to aortic and mitral regurgitation. Circulation 2003;108:2432-2438. Borer JS. New perspectives for the treatment of stable angina in If Current Inhibition in Treatment of Angina Pectoris (ed: Fox K), Science Press (London) 2003, pp. 51-62. Borer JS. Indications for valve replacement in aortic regurgitation in Harrison’s Online (Harrison’s Principles of Internal Medicine on line updates) (Braunwald E, ed), McGraw-Hill (New York), 2003, www.harrisononline.com,, addendum to Chapter 236:Valvular Heart Disease, 6pp. Borer J, Supino P, Truter S, Herrold E, Hochreiter C, Gupta A, Yin A, Lee E, Pitlor L, Krieger K, Isom O. Aortic regurgitation: contractility as primary prognosticator and basis of the contractile deficit. Proceedings of 3rd International Congress on Heart Disease – New Trends in Research, Diagnosis and Treatment (Kimchi A, ed), Monduzzi Editore: Bologna, 2003, pp. 449-453. Borer JS. Angina prevention by heart rate slowing: If current blockade with ivabradine. Frontiers in Coronary Artery Disease, Proceedings of the 5th International Congress on Coronary Artery Disease (Lewis B, Halon DA, Flugelman MY, Gensini GF, eds), Moduzzi Editore: Bologna, 2003 pp 487-491.
Borer JS, Truter S, Herrold EM, Supino P, Carter JN, Gupta A. The cellular and molecular basis of heart failure in regurgitant valvular diseases: the myocardial extracellular matrix as a building block for future therapy. Advances in Cardiology 2002;39:7-14. Borer JS, Herrold EM, Hochreiter CA, Supino PG, Yin A, Krieger K, Isom OW. Aortic regurgitation: selection of asymptomatic patients for valve surgery. Advances in Cardiology 2002;39:74-85. Hochreiter C, Borer JS, Herrold EM, Supino PG, Krieger K, Isom OW. Mitral regurgitation: natural history in operated and unoperated patients. Advances in Cardiology 2002;39:122-129. Borer JS, Hochreiter CA, Supino PG, Herrold EH, Krieger K, Isom OW. The importance of right ventricular performance measurement in selecting asymptomatic patients with mitral regurgitation for valve surgery. Advances in Cardiology 2002;39:144-152. Borer JS, Truter SL, Herrold EM, Falcone DJ, Pena M, Carter JN, Dumlao T, Lee J, Supino PG. Myocardial fibrosis in chronic aortic regurgitation: molecular and cellular response to volume overload. Circulation 2002;105:1837-1842. Borer JS, Herrold EM, Truter S, Hochreiter C, Supino P, Krieger K, Isom OW. The biology of regurgitant valvular diseases: pathophysiology of heart failure and relation to future therapy in Advances in Heart Failure (Proceedings of the 8th World Congress on Heart Failure, Kimchi A, ed.), Monduzzi Editore (Bologna), 2002, pp. 451-456. Borer JS. Aortic valve replacement for the asymptomatic patient with aortic regurgitation: a new piece of the strategic puzzle. Circulation 2002; 106:2637-2639.
Borer JS, Fenichel R, Stockbridge N, Throckmorton D, Karkowsky A, Lipicky R, Orloff D, Siegel JP, Somberg JC, DeFelice A, Walton M. Proceedings of the Nineteenth Annual Symposium: Advances in Cardiovascular Pharmacology – Protocol Design and Methodology. The U.S. Regulatory Process. American Journal of Therapeutics 2001;8:187-219. Borer J. Regurgitant valvular diseases: relation of fundamental biology and clinical outcomes, in Heart Disease: New Trends in Research, Diagnosis and Treatment (Kimchi A, ed), Medimond: New York, 2001, pp. 679-684. Supino PG, Borer JS, Yin A. The epidemiology of valvular heart disease: an emerging public health problem. Advances in Cardiology 2001;39:1-6. Borer JS, Supino P, Hochreiter C, Herrold EM, Bornstein A, Yin A, Swan C, Krieger K, Isom OW. Effect of coronary artery bypass grafting on fatal and non-fatal complications early after surgery for non-ischemic valvular heart disease and associated coronary artery disease. Coronary Artery Disease: Prevention to Intervention; Proceedings of the 4rd International Congress on Coronary Artery Disease (Lewis B, Halon D, Flugelman M, Hradec M, eds), Monduzzi Editore: Bologna, 2001, pp. 119-125.
Truter SL, Goldin D, Kolesar J, Dumlao TF, Borer JS. Abnormal gene expression of cardiac fibroblasts in experimental aortic regurgitation. American Journal of Therapeutics, 2000; 7:237-243. Singh RG, Capucci R, Kramer-Fox R, Roman MH, Kligfield P, Borer JS, Hochreiter C, Isom OW, Devereux RB. Severe mitral regurgitation due to mitral valve prolapse: risk factors for development, progression and need for mitral valve surgery. American Journal of Cardiology, 2000; 85:193-198 Wencker D,Borer JS, Hochreiter C, Devereux RB, Roman MJ, Kligfield P, Supino P, Krieger K, Isom OW. Preoperative predictors of late postoperative outcome among patients with non-ischemic mitral regurgitation with “high risk” descriptors, and comparison with unoperated patients. Cardiology, 2000; 93:37-42. Borer J, Supino P, Hochreiter C, Herrold E, Devereux R, Roman M, Kligfield P, Krieger K, Isom O, Yin A. Impact of coronary disease on survival after valve replacement for non-ischemic valve disease. Coronary Artery Disease: Prevention to Intervention; Proceedings of the 3rd International Congress on Coronary Artery Disease (Lewis B, Halon D, Flugelman M, Touboul P, eds), Monduzzi Editore (Bologna), 2000, pp. 173-178.
|
||||||||||||||||
 |
 |
||||||||||||||||
